Vita 34 Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Vita 34 AG
Access all reports
Vita 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company also manufactures and sells reagents for bone marrow diagnostics. Its products include frozen cord blood units, partal bio-banking, culture and expansion f IMR90 K1, hematopoietic stem cells, adult progenitor cells, endothelial progenitor cells Mitomycin C; Vitapur; Vitafrost; Vitastem ampoules; sweet-hand sterilization bags for various applications; freezing bag for ten freezing bags; and pipette with tips. The company was founded in 1997 and is headquartered in Leipzig, Germany.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
V3V
Country
đ©đȘ Germany